Back to search results

Mobile Health Intervention for Oral Anticancer Therapy Adherence

This study is testing a new mobile health (mHealth) program called SMART, which uses TAPPT® smart labels and a web app. The goal is to help people with cancer take their oral anticancer therapy (OAT) medications correctly and manage any side effects. The SMART program offers personalized text reminders, surveys about medication and symptoms, and support for financial and social needs. We want to see if this program is easy to use and helpful for patients. You might be able to join if you are 18 or older, speak English or Spanish, have any type of cancer, and have recently started or are about to start an oral anticancer medication. You also need to be receiving treatment at UCI Chao Family Comprehensive Cancer Center and own a smartphone. This study plans to enroll 35 participants, but the current status is unclear.

Study design
This is a single-arm study, meaning everyone receives the same intervention. It will involve 35 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months from when the intervention starts.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07073807

Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy

Completed
NAAges 18+InterventionalHealth services
University of California, Irvine
~35 participants
Updated 2026-08-07 on ClinicalTrials.gov
What's tested:SMART Intervention using TAPPT® for Adherence, Symptom, Financial, and Social Needs Monitoring

At a glance

Recruiting sites
0 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of the SMART Intervention
Measured over 3 months from intervention initiation
+1 more outcome measured

Conditions

Cancer
Neoplasms

Explore related trials

Malignant Neoplasm

Where it's being run

5 sites across 1 states
California5

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Must speak English or Spanish
Must be 18 years of age or older
Have a diagnosis of any type and stage of cancer
Have a new prescription for an oral anticancer therapy (OAT) initiated within the last 90 days or planned to start within the next 15 days
Be receiving treatment at UCI Chao Family Comprehensive Cancer Center-affiliated oncology clinics
Own a smartphone and be willing to receive study-related text messages.

Exclusion

Have an Eastern Cooperative Oncology Group (ECOG) performance status greater than 2
Be medically or cognitively unable to give consent or participate in the study
Be participating in another clinical trial that monitors adherence or symptoms related to the newly prescribed OAT

What this trial measures

  • Feasibility of the SMART Intervention3 months from intervention initiation

    Feasibility will be assessed by the proportion of participants using TAPPT® adherence monitoring for the duration of therapy and the proportion completing all available biweekly surveys.

  • Acceptability of the SMART Intervention3 months from intervention initiation

    Acceptability will be measured by participant ratings on the System Usability Scale (0-100; higher scores indicating greater usability).